Biotechnology - Asia-Pacific, Immunologicals

Filter

Popular Filters

Osiris gets second approval for Prochymal, in New Zealand

15-06-2012

USA-based Osiris Therapeutics (Nasdaq: OSIR) has received a second approval to market its first-in-class…

Asia-PacificBiotechnologyImmunologicalsOsiris TherapeuticsProchymalRegulation

Astellas in-licenses antibody from Evec; Mitsubishi Tanabe deal with Synageva

06-09-2011

Japanese biotech firm Evec has entered a license agreement for one of its fully-human antibodies against…

Asia-PacificAstellas PharmaBiotechnologyEvecImmunologicalsLicensingMitsubishi TanabePharmaceuticalRare diseasesResearchSynageva BioPharma

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top